Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats. 2003

Linda Paulson, and Peter Martin, and Anders Persson, and Carol L Nilsson, and Elisabeth Ljung, and Ann Westman-Brinkmalm, and Peter S Eriksson, and Kaj Blennow, and Pia Davidsson
Department of Clinical Neuroscience, Göteborg University, Göteborg, Sweden. linda.paulson@neuro.gu.se

cDNA microarrays and two-dimensional gel-electrophoresis in combination with mass spectrometry, were used to screen alterations in mRNA and protein levels, respectively, in cerebral cortex of MK-801-treated rats. The rats were divided in two groups; group 1 (short-term treated) and group 2 (long-term treated). In group 1, four genes were up-regulated and five down-regulated. In group 2, seven genes were up-regulated and six down-regulated. In group 1, the levels of one protein was increased and eight proteins reduced. In group 2, the levels of two proteins were increased and four proteins reduced. Several of the altered genes (casein kinase 2, glutamic acid decarboxylase, synaptotagmin, gamma aminobutyric acid [GABA] transporter, creatine kinase, and cytochrome c oxidase) and proteins (superoxide dismutase, hsp 60, hsp 72 and gamma-enolase) have previously been connected to schizophrenia. Alterations of the genes (microglobulin, c-jun proto-oncogene, 40S ribosomal protein S19, adenosine diphosphate (ADP)-ribosylation factors, platelet-derived growth factor, fructose-bisphophate aldolase A, and myelin proteolipid) and the proteins (stathmin, H+-transp. Adenosine triphosphate (ATP) synthase, pyruvate dehydrogenase, beta-actin and alpha-enolase), have not, to our knowledge, earlier been implicated in schizophrenia pathology. Overall, these results with a combined approach of genomics and proteomics add to the validity of subchronic N-methyl-D-aspartate (NMDA)-receptor antagonist treatment as an animal model of schizophrenia.

UI MeSH Term Description Entries
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D016291 Dizocilpine Maleate A potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) used mainly as a research tool. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role. Its use has been primarily limited to animal and tissue experiments because of its psychotropic effects. Dizocilpine,MK-801,MK 801,MK801
D016678 Genome The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA. Genomes
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D020411 Oligonucleotide Array Sequence Analysis Hybridization of a nucleic acid sample to a very large set of OLIGONUCLEOTIDE PROBES, which have been attached individually in columns and rows to a solid support, to determine a BASE SEQUENCE, or to detect variations in a gene sequence, GENE EXPRESSION, or for GENE MAPPING. DNA Microarrays,Gene Expression Microarray Analysis,Oligonucleotide Arrays,cDNA Microarrays,DNA Arrays,DNA Chips,DNA Microchips,Gene Chips,Oligodeoxyribonucleotide Array Sequence Analysis,Oligonucleotide Microarrays,Sequence Analysis, Oligonucleotide Array,cDNA Arrays,Array, DNA,Array, Oligonucleotide,Array, cDNA,Arrays, DNA,Arrays, Oligonucleotide,Arrays, cDNA,Chip, DNA,Chip, Gene,Chips, DNA,Chips, Gene,DNA Array,DNA Chip,DNA Microarray,DNA Microchip,Gene Chip,Microarray, DNA,Microarray, Oligonucleotide,Microarray, cDNA,Microarrays, DNA,Microarrays, Oligonucleotide,Microarrays, cDNA,Microchip, DNA,Microchips, DNA,Oligonucleotide Array,Oligonucleotide Microarray,cDNA Array,cDNA Microarray

Related Publications

Linda Paulson, and Peter Martin, and Anders Persson, and Carol L Nilsson, and Elisabeth Ljung, and Ann Westman-Brinkmalm, and Peter S Eriksson, and Kaj Blennow, and Pia Davidsson
January 2013, PloS one,
Linda Paulson, and Peter Martin, and Anders Persson, and Carol L Nilsson, and Elisabeth Ljung, and Ann Westman-Brinkmalm, and Peter S Eriksson, and Kaj Blennow, and Pia Davidsson
October 1997, Experimental neurology,
Linda Paulson, and Peter Martin, and Anders Persson, and Carol L Nilsson, and Elisabeth Ljung, and Ann Westman-Brinkmalm, and Peter S Eriksson, and Kaj Blennow, and Pia Davidsson
December 2013, Behavioural pharmacology,
Linda Paulson, and Peter Martin, and Anders Persson, and Carol L Nilsson, and Elisabeth Ljung, and Ann Westman-Brinkmalm, and Peter S Eriksson, and Kaj Blennow, and Pia Davidsson
May 2000, Drug and alcohol dependence,
Linda Paulson, and Peter Martin, and Anders Persson, and Carol L Nilsson, and Elisabeth Ljung, and Ann Westman-Brinkmalm, and Peter S Eriksson, and Kaj Blennow, and Pia Davidsson
April 2011, European archives of psychiatry and clinical neuroscience,
Linda Paulson, and Peter Martin, and Anders Persson, and Carol L Nilsson, and Elisabeth Ljung, and Ann Westman-Brinkmalm, and Peter S Eriksson, and Kaj Blennow, and Pia Davidsson
November 1990, Stroke,
Linda Paulson, and Peter Martin, and Anders Persson, and Carol L Nilsson, and Elisabeth Ljung, and Ann Westman-Brinkmalm, and Peter S Eriksson, and Kaj Blennow, and Pia Davidsson
December 1992, Acta physiologica Scandinavica,
Linda Paulson, and Peter Martin, and Anders Persson, and Carol L Nilsson, and Elisabeth Ljung, and Ann Westman-Brinkmalm, and Peter S Eriksson, and Kaj Blennow, and Pia Davidsson
February 1998, The Journal of urology,
Linda Paulson, and Peter Martin, and Anders Persson, and Carol L Nilsson, and Elisabeth Ljung, and Ann Westman-Brinkmalm, and Peter S Eriksson, and Kaj Blennow, and Pia Davidsson
October 1990, Brain research,
Linda Paulson, and Peter Martin, and Anders Persson, and Carol L Nilsson, and Elisabeth Ljung, and Ann Westman-Brinkmalm, and Peter S Eriksson, and Kaj Blennow, and Pia Davidsson
December 1991, Brain research. Developmental brain research,
Copied contents to your clipboard!